Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 100
Gene Symbol: ADA
ADA
0.020 Biomarker phenotype BEFREE According to ADA criteria, 588 (74.6%) women were normal, 46 (5.8%) had impaired fasting glucose, 82 (10.4%) had impaired glucose tolerance, 29 (3.7%) had both impaired fasting glucose and impaired glucose tolerance, and 43 (5.4%) had diabetes. 10388966 1999
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.100 Biomarker phenotype BEFREE The aim of this study was to investigate the mRNA expression pattern of the two TNF receptors and their ligand in two adipose tissue depots of glucose-tolerant obese women [n = 18, body mass index (BMI) 48.2 +/- 8.4 kg m-2], obese women with impaired glucose tolerance or overt non-insulin-dependent diabetes mellitus (NIDDM) (n = 10, BMI 49.1 +/- 11.6 kg m-2) and healthy non-obese control subjects (n = 12, BMI 25.8 +/- 2.7 kg m-2). 10457150 1999
Entrez Id: 3119
Gene Symbol: HLA-DQB1
HLA-DQB1
0.010 GeneticVariation phenotype BEFREE (a) To study whether there was an increased prevalence of glucose intolerance in the parents of probands with Type 1 diabetes and (b) to look for any possible link between the glucose intolerance in the parents with HLA-DQB1 alleles transmitted in excess to the Type 1 diabetes offspring. 10585618 1999
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
0.040 AlteredExpression phenotype BEFREE The increase in aromatase activity in our patient may have led to a low serum concentration of DHEA that in turn caused glucose intolerance and a deterioration of the diabetes prior to admission. 10596729 2000
Entrez Id: 6927
Gene Symbol: HNF1A
HNF1A
0.070 GeneticVariation phenotype BEFREE To evaluate insulin secretion and sensitivity in affected (diabetes mellitus or impaired glucose tolerance; n=7) and in unaffected (normal glucose tolerance; n=3) carriers of hepatocyte nuclear factor-1alpha (maturity-onset diabetes of the young-3 (MODY3)) gene mutations. 10601964 1999
Entrez Id: 6927
Gene Symbol: HNF1A
HNF1A
0.070 GeneticVariation phenotype BEFREE Because HNF1A S319 was not the only predisposing factor for diabetes in the Oji-Cree, subjects without HNF1A S319 were still at some risk for diabetes or IGT. 10840995 2000
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.600 Biomarker phenotype BEFREE Abnormalities of sympathetic effects, including disturbances of leptin and beta3-adrenergic receptor signalling, are likely to cause obesity and impaired glucose tolerance in rodents and humans. 10855527 2000
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.400 AlteredExpression phenotype BEFREE In Type 2 diabetes the regularity of the oscillations disappears, which may lead to insulin receptor down-regulation and glucose intolerance and explain why pulsatile delivery of the hormone has a greater hypoglycemic effect than continuous delivery.The rhythm is intrinsic to the islet. 10867718 2000
Entrez Id: 5506
Gene Symbol: PPP1R3A
PPP1R3A
0.010 GeneticVariation phenotype BEFREE The aim of this study was to investigate whether two common variants in the PPP1R3 gene, Asp905Tyr and PP1ARE, are associated with reduced insulin sensitivity or can predict the development of impaired glucose tolerance (IGT) or type 2 diabetes during a 20-year follow-up period in 696 50-year-old Caucasian men. 10868947 2000
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker phenotype BEFREE These findings demonstrate the importance of the normal inverse relationship between serum insulin and IGFBP-1 levels in glucoregulation and that sustained dysregulation of the insulin/IGF-I/IGFBP-1 axis is associated with impaired glucose tolerance and abnormalities of insulin action. 10868969 2000
Entrez Id: 3484
Gene Symbol: IGFBP1
IGFBP1
0.010 Biomarker phenotype BEFREE Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. 10868969 2000
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.400 Biomarker phenotype CTD_human Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. 10949030 2000
Entrez Id: 102723407
Gene Symbol: LOC102723407
LOC102723407
0.100 GeneticVariation phenotype BEFREE Of the case subjects, 23% were glucose intolerant (4% with diabetes and 19% with impaired glucose tolerance [IGT]) compared with 6.5% (all with IGT) of control subjects (P = 0.02). 11128348 2000
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.110 GeneticVariation phenotype BEFREE Rare mutations in LMNA were recently shown to underlie familial partial lipodystrophy (FPLD), a syndrome characterized by regional loss of adipose tissue, insulin resistance, and glucose intolerance. 11243729 2001
Entrez Id: 154
Gene Symbol: ADRB2
ADRB2
0.020 GeneticVariation phenotype BEFREE We conclude that the beta(2)-AR gene (Gln27Glu) variant might not be an important factor for obesity or IGT in Japanese subjects. 11288039 2001
Entrez Id: 338
Gene Symbol: APOB
APOB
0.040 Biomarker phenotype BEFREE After adjustment for age and sex, lower HDL cholesterol (P=0.005), higher serum triglycerides (P<0.001), apolipoprotein B (P=0.039) and 2-h insulin (P<0.001) were still associated with post-transplant glucose intolerance. 11328915 2001
Entrez Id: 93
Gene Symbol: ACVR2B
ACVR2B
0.010 Biomarker phenotype BEFREE Transgenic and knock-out mice for the ACVR2B gene display various endocrine pancreas-related abnormalities, including islet hypoplasia and glucose intolerance, demonstrating the crucial role of ACVR2B in the regulation of pancreas development. 11334431 2001
Entrez Id: 4160
Gene Symbol: MC4R
MC4R
0.040 Biomarker phenotype BEFREE Likewise, its homologous MC4R in human obesity, MC3R gene is also a good candidate for genetic susceptibility to glucose intolerance and T2DM. 11397906 2001
Entrez Id: 4159
Gene Symbol: MC3R
MC3R
0.010 Biomarker phenotype BEFREE Likewise, its homologous MC4R in human obesity, MC3R gene is also a good candidate for genetic susceptibility to glucose intolerance and T2DM. 11397906 2001
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
0.040 Biomarker phenotype BEFREE The alphaERKO mice also had insulin resistance and impaired glucose tolerance, similar to humans lacking ERalpha or aromatase. 11403904 2001
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.540 GeneticVariation phenotype BEFREE Three LEPR polymorphisms (Lys(109)Arg, Gln(223)Arg, and Lys(656)Asn) were typed on genomic DNA of 358 overweight and obese women, aged 18-60 yr. Based on an OGTT, 269 subjects were defined with normal glucose tolerance, and 89 with impaired glucose tolerance (IGT). 11443193 2001
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.210 Biomarker phenotype CTD_mouse Early fructose dietary treatment results in moderate hypertension and glucose intolerance, which is prevented by a single neonatal treatment with AT1R-AS. 11564974 2001
Entrez Id: 2169
Gene Symbol: FABP2
FABP2
0.020 GeneticVariation phenotype BEFREE (1) The Ala54 and Thr54 allele frequencies in Chinese were 0.71 and 0.29 respectively; (2) The FABP2-Ala54Thr variation was neither associated with fasting and post-challenged plasma glucose levels nor with NIDDM; (3) This variation was neither associated with fasting lipid profile nor with obesity; (4) The IGT subjects with genotype Thr54(+) (Thr54 homozygotes and heterozygotes) had lower fasting, 2-hour and total C-peptide levels and smaller AUC representing lesser C-peptide secretion after glucose challenge than those with genotype Thr54(-) (Ala54 homozygotes) (P = 0.04, 0.03, 0.01 and 0.01 respectively). 11593593 1999
Entrez Id: 3651
Gene Symbol: PDX1
PDX1
0.060 Biomarker phenotype BEFREE Heterozygous mutations in the gene result in impaired glucose tolerance and symptoms of diabetes as seen in MODY4 and late-onset Type II (non-insulin-dependent) diabetes mellitus. 11692168 2001
Entrez Id: 5080
Gene Symbol: PAX6
PAX6
0.140 GeneticVariation phenotype BEFREE Oral glucose tolerance tests revealed that all of the patients with a PAX6 gene mutation had glucose intolerance characterized by impaired insulin secretion. 11756345 2002